{"survey":"PAN-2012-VEEV","total":20,"counts":14,"age_min":1,"age_max":10,"tsur":2012,"country":"PAN","test":"ELISA","antibody":"IgG anti-VEEV"}
{"survey":"PAN-2012-VEEV","total":22,"counts":16,"age_min":11,"age_max":20,"tsur":2012,"country":"PAN","test":"ELISA","antibody":"IgG anti-VEEV"}
{"survey":"PAN-2012-VEEV","total":13,"counts":12,"age_min":21,"age_max":30,"tsur":2012,"country":"PAN","test":"ELISA","antibody":"IgG anti-VEEV"}
{"survey":"PAN-2012-VEEV","total":3,"counts":3,"age_min":31,"age_max":40,"tsur":2012,"country":"PAN","test":"ELISA","antibody":"IgG anti-VEEV"}
{"survey":"PAN-2012-VEEV","total":5,"counts":5,"age_min":41,"age_max":50,"tsur":2012,"country":"PAN","test":"ELISA","antibody":"IgG anti-VEEV"}
{"survey":"PAN-2012-VEEV","total":10,"counts":7,"age_min":51,"age_max":60,"tsur":2012,"country":"PAN","test":"ELISA","antibody":"IgG anti-VEEV"}